Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    LAVA Medtech Acquisition ...

    NASDAQ: LVACU · Real-Time Price · USD
    10.40
    0.00 (0.00%)
    At close: Apr 19, 2023, 5:46 PM

    LAVA Medtech Acquisition Statistics

    Share Statistics

    LAVA Medtech Acquisition has - shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 n/a

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 8.91M

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is 32.52 and the forward PE ratio is null. LAVA Medtech Acquisition's PEG ratio is -0.43.

    PE Ratio

    n/a
    		 32.52

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 1.26

    P/FCF Ratio

    n/a
    		 -222.34

    PEG Ratio

    n/a
    		 -0.43
    Financial Ratio History

    Enterprise Valuation

    LAVA Medtech Acquisition has an Enterprise Value (EV) of 145.32M.

    EV / Sales

    n/a
    		 0

    EV / EBITDA

    n/a
    		 -23.36

    EV / EBIT

    n/a
    		 -220.58

    EV / FCF

    n/a
    		 -220.58

    Financial Position

    The company has a current ratio of 0.29, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 0.29

    Quick Ratio

    n/a
    		 0.29

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0.25

    Financial Efficiency

    Return on Equity is 3.89% and Return on Invested Capital is -1.26%.

    Return on Equity

    n/a
    		 3.89%

    Return on Assets

    n/a
    		 3.73%

    Return on Invested Capital

    n/a
    		 -1.26%

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 n/a

    Employee Count

    n/a
    		 undefined

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 304.29K

    Effective Tax Rate

    n/a
    		 6.33%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 0, so LAVA Medtech Acquisition's price volatility has been lower than the market average.

    Beta

    n/a
    		 0

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 10.41

    200-Day Moving Average

    n/a
    		 10.23

    Relative Strength Index (RSI)

    n/a
    		 38.9

    Average Volume (20 Days)

    n/a
    		 80

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -1.56M

    Net Income

    n/a
    		 4.5M

    EBITDA

    n/a
    		 -6.22M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 0.31
    Full Income Statement

    Balance Sheet

    The company has 1.16M in cash and 0 in debt, giving a net cash position of 1.16M.

    Cash & Cash Equivalents

    n/a
    		 1.16M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -3.01M

    Total Assets

    n/a
    		 120.67M

    Working Capital

    n/a
    		 -3.39M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -658.82K and capital expenditures 0, giving a free cash flow of -658.82K.

    Operating Cash Flow

    n/a
    		 -658.82K

    Capital Expenditures

    n/a
    		 n/a

    Free Cash Flow

    n/a
    		 -658.82K

    FCF Per Share

    n/a
    		 -0.05
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    LVACU does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 3.08%

    FCF Yield

    n/a
    		 -0.45%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for LVACU.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 18.75

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist